Australian Dementia Network announced
The Australian Dementia Network (ADNet), a registry and research program will accelerate dementia research in Australia with memory centres and a registry of clinical trial volunteers.
Aged Care Minister Ken Wyatt said the Federal Government’s $18 million allocation to the Australian-first project would be increased by a further $20 million in commitments from universities, philanthropists, industry, research centres and State governments.
It’s estimated 1,700 Australians a week are joining the population living with dementia and without breakthroughs that figure will reach 650 a day by 2050.
Dementia is the biggest killer of Australian women and the second most common cause of death among the overall population, claiming more than 13,000 lies each year.
- Establish a national network of memory clinics to speed assessment of cognitive disorders and improve specialist access for all Australians, through advanced imaging, genetics and lifestyle data
- Register and prepare volunteers for participation in clinical trials and other research programs, by providing them with state of the art diagnosis and tracking their disease trajectory
- Collate and compare data to chart dementia causes, progression and risks and potential new treatments, while supporting research participants and benchmarking clinical care
- Ensure Australian and international data can be shared, providing unprecedented research access to global data and collaboration, to inform prevention, treatment and care.
“Through ADNeT, Australia joins the international push to use large-scale national registries to expedite research and beat dementia,” said Mr Wyatt.
“By significantly increasing public access to, and participation in, clinical trials it will also speed the development and approval of new prevention and treatment therapies.”
ADNet will drive research and deliver improvements through five core teams - Registry, Clinics, Trials, Technology and Business - with close links to leading international programs in Europe and the USA.
Professor Christopher Rowe of Austin Health will lead ADNet, as Chief Investigator.
ADNeT is the largest single project funded to date through the Government’s $200 million, five-year Boosting Dementia Research Initiative launched in 2014 by the National Health and Medical Research Council (NHMRC).
The 2018 Federal Budget funding includes a further $5.3 million to conduct a dementia innovation trial.
Since 2015, NHMRC’s National Institute for Dementia Research (NNIDR) has been targeting, coordinating and translating the strategic expansion of dementia research in Australia.
NNIDR is committed to achieving the World Dementia Council’s international target – a five-year delay in the onset of dementia by 2025.
National Dementia Helpline is available on telephone 1800 100 500. An interpreter service is available.
See Dementia Australia at www.dementia.org.au
3 July 2018.